Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 223,761,506 papers from all fields of science
Search
Sign In
Create Free Account
monoclonal antibody LL2
Known as:
LL2
, LL2 monoclonal antibody
, MoAb LL2
Expand
A murine monoclonal antibody (MoAb) IgG2a, LL2. MoAb LL2 recognizes CD22, a B-lymphocyte-restricted antigen expressed as a cytoplasmic protein in…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Monoclonal Antibodies
antigen binding
epratuzumab
technetium Tc 99m monoclonal antibody LL2
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Lymphoma imaging with a new technetium-99m labelled antibody, LL2
S. Murthy
,
R. Sharkey
,
+5 authors
L. C. Swayne
European Journal of Nuclear Medicine
2004
Corpus ID: 23322849
The lesion detection capability of a new technetium-99m labelled B-cell lymphoma monoclonal antibody (MoAb) imaging agent, LL2…
Expand
2000
2000
Specific binding of sterically stabilized anti-B-cell immunoliposomes and cytotoxicity of entrapped doxorubicin.
B. Lundberg
,
G. Griffiths
,
H. Hansen
International journal of pharmaceutics
2000
Corpus ID: 27778058
1999
1999
Conjugation of an Anti‐B‐cell Lymphoma Monoclonal Antibody, LL2, to Long‐circulating Drug‐carrier Lipid Emulsions
B. Lundberg
,
G. Griffiths
,
H. Hansen
The Journal of pharmacy and pharmacology
1999
Corpus ID: 24848997
Long‐circulating submicron lipid emulsions, stabilized with poly(ethylene glycol)‐modified phosphatidylethanolamine (PEG‐PE), are…
Expand
1999
1999
Labeling of monoclonal antibodies with diethylenetriaminepentaacetic acid-appended radioiodinated peptides containing D-amino acids.
S. V. Govindan
,
M. Mattes
,
+5 authors
G. Griffiths
Bioconjugate chemistry
1999
Corpus ID: 30257834
The optimal use of radioiodinated internalizing monoclonal antibodies (mAbs) for radioimmunotherapy necessitates the development…
Expand
1998
1998
Carbohydrates engineered at antibody constant domains can be used for site-specific conjugation of drugs and chelates.
Z. Qu
,
R. Sharkey
,
+5 authors
S. Leung
JIM - Journal of Immunological Methods
1998
Corpus ID: 34360221
1997
1997
The advantage of residualizing radiolabels for targeting B‐cell lymphomas with a radiolabeled anti‐CD22 monoclonal antibody
M. Mattes
,
L. Shih
,
+4 authors
D. Goldenberg
International Journal of Cancer
1997
Corpus ID: 304330
CD22 antibodies (Abs) bound to B‐cell lymphomas are known to be internalized and catabolized rapidly. Therefore, it would be…
Expand
1995
1995
Site-specific modifications of light chain glycosylated antilymphoma (LL2) and anti-carcinoembryonic antigen (hImmu-14-N) antibody divalent f1agments.
S. V. Govindan
,
D. Goldenberg
,
G. Griffiths
,
S. Leung
,
M. Losman
,
H. Hansen
Cancer Research
1995
Corpus ID: 37513011
Site-specific introduction of metal-chelating groups into F(ab')2 fragments of an antilymphoma antibody (LL2) possessing a…
Expand
1992
1992
Mycoplasma simbae sp. nov., Mycoplasma leopharyngis sp. nov., and Mycoplasma leocaptivus sp. nov., isolated from lions.
A. Hill
International Journal of Systematic Bacteriology
1992
Corpus ID: 10070877
Mycoplasmas isolated from the throats of lions were shown to belong to three serotypes, all of which were serologically distinct…
Expand
1989
1989
Replication of measles virus in the human plasma cell leukemia-derived LICR-LON-HMy2 cell line.
B. Ziola
,
M. Morhart
,
L. Gilbert
,
B. Karvonen
,
X. P. Chen
Journal of Virological Methods
1989
Corpus ID: 4052370
1989
1989
Adhesive and motile properties of Lewis lung carcinoma LL2 lines.
J. Doroszewski
,
M. Nowak-Wyrzykowska
,
W. Waleszczyk
Archivum Immunologiae et Therapiae Experimentalis
1989
Corpus ID: 35040128
The cell substrate adhesion of the Lewis lung carcinoma in vitro maintained sublines (LL2 basic line, WGA-resistant LL2-8, and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE